Search Results - "Keech, Cheryl A"
-
1
A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults
Published in The Pediatric infectious disease journal (01-04-2020)“…BACKGROUND:Broadly protective pneumococcal vaccines that are affordable for low-resource countries are needed. Streptococcus pneumoniae whole cell vaccine…”
Get full text
Journal Article -
2
Year-by-year analysis of cardiovascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial
Published in Current medical research and opinion (01-01-2005)“…ABSTRACT Objective: To assess the effect of raloxifene 60 mg/day (RLX) on year-by-year cardiovascular (CV) events in postmenopausal women participating in the…”
Get full text
Journal Article -
3
Safety assessment of raloxifene over eight years in a clinical trial setting
Published in Current medical research and opinion (01-09-2005)“…ABSTRACT Objective: Osteoporosis is a chronic disorder that warrants long-term therapy. If benefits are to outweigh risks, the long-term safety profiles of…”
Get full text
Journal Article -
4
Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics, and effect of raloxifene
Published in Menopause (New York, N.Y.) (01-07-2005)“…OBJECTIVE:To determine the incidence of arterial and venous thromboembolic (VTE) events, to determine the effect of raloxifene on the incidence of combined…”
Get full text
Journal Article -
5
Carotid artery intima-media thickness after raloxifene treatment
Published in Journal of women's health (Larchmont, N.Y. 2002) (01-04-2007)“…Raloxifene, a selective estrogen receptor modulator (SERM), decreases total and low-density lipoprotein cholesterol (LDL-C) in postmenopausal women and…”
Get more information
Journal Article -
6
Effects of raloxifene and low-dose simvastatin coadministration on plasma lipids in postmenopausal women with primary hypercholesterolemia
Published in Metabolism, clinical and experimental (01-07-2005)“…Raloxifene and low-dose simvastatin can each reduce low-density lipoprotein (LDL) cholesterol without affecting high-density lipoprotein (HDL) cholesterol and…”
Get full text
Journal Article -
7
1183. Serum Bactericidal Activity Induced by Live Attenuated Pertussis Vaccine BPZE1 is Comparable to Boostrix
Published in Open forum infectious diseases (04-12-2021)“…Abstract Background In a Phase 2b, multi-center, placebo-controlled, randomized study, intranasal BPZE1 induced mucosal and serum antibodies to pertussis…”
Get full text
Journal Article -
8
-
9
Interaction of basal positive and negative transcription elements controls repression of the proximal rat prolactin promoter in nonpituitary cells
Published in Molecular and Cellular Biology (01-06-1992)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
10
Cyclic adenosine 3',5'-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type
Published in Molecular endocrinology (Baltimore, Md.) (01-12-1992)“…Pituitary lactotroph cell function and PRL gene expression are highly regulated by the cAMP-protein kinase-A (PKA) pathway. To further our understanding of the…”
Get more information
Journal Article -
11
Insulin activation of rat prolactin promoter activity
Published in Molecular and cellular endocrinology (01-06-1991)“…The role of insulin regulation of rat prolactin (rPRL) gene transcription was studied using GH4 rat pituitary tumor cells transiently transfected with plasmids…”
Get more information
Journal Article -
12
Interaction of Basal Positive and Negative Transcription Elements Controls Repression of the Proximal Rat Prolactin Promoter in Nonpituitary Cells
Published in Molecular and cellular biology (01-06-1992)“…The proximal rat prolactin (rPRL) promoter contains three cell-specific elements, designated footprints I, III, and IV, which restrict rPRL gene expression to…”
Get full text
Journal Article